Related references
Note: Only part of the references are listed.AHR in the intestinal microenvironment: safeguarding barrier function
Brigitta Stockinger et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
Tryptophan (Trp) modulates gut homeostasis via aryl hydrocarbon receptor (AhR)
Meige Sun et al.
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2020)
Association Between Microscopic Lesions at Ileal Resection Margin and Recurrence After Surgery in Patients With Crohn's Disease
Nassim Hammoudi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Prominence of ileal mucosa-associated microbiota to predict postoperative endoscopic recurrence in Crohn's disease
Harry Sokol et al.
GUT (2020)
Mitochondrial impairment drives intestinal stem cell transition into dysfunctional Paneth cells predicting Crohn's disease recurrence
Sevana Khaloian et al.
GUT (2020)
Postoperative Endoscopic Recurrence on the Neoterminal Ileum But Not on the Anastomosis Is Mainly Driving Long-Term Outcomes in Crohn's Disease
Nassim Hammoudi et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2020)
Randomised trial and open-label extension study of an anti-interleukin-6 antibody in Crohn's disease (ANDANTE I and II)
Silvio Danese et al.
GUT (2019)
T cell clonal expansions in ileal Crohn's disease are associated with smoking behaviour and postoperative recurrence
Matthieu Allez et al.
GUT (2019)
Ileal Gene Expression Data from Crohn's Disease Small Bowel Resections Indicate Distinct Clinical Subgroups
Alka A. Potdar et al.
JOURNAL OF CROHNS & COLITIS (2019)
Efficacy of Ruxolitinib Therapy in a Patient With Severe Enterocolitis Associated With a STAT3 Gain-of-Function Mutation
Marianna Parlato et al.
GASTROENTEROLOGY (2019)
Gene and Mirna Regulatory Networks During Different Stages of Crohn's Disease
Sare Verstockt et al.
JOURNAL OF CROHNS & COLITIS (2019)
Molecular classification of Crohn's disease reveals two clinically relevant subtypes
Matthew Weiser et al.
GUT (2018)
Review article: novel oral-targeted therapies in inflammatory bowel disease
J. R. White et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
The JAK inhibitor ruxolitinib reduces inflammation in an ILC3-independent model of innate immune colitis
A. M. Overstreet et al.
MUCOSAL IMMUNOLOGY (2018)
Contribution of STAT3 to Inflammatory and Fibrotic Diseases and Prospects for its Targeting for Treatment
Moses M. Kasembeli et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Interaction between smoking and ATG16L1T300A triggers Paneth cell defects in Crohn's disease
Ta-Chiang Liu et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Male gender, active smoking and previous intestinal resection are risk factors for post-operative endoscopic recurrence in Crohn's disease: results from a prospective cohort study
Claire Auzolle et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial
Severine Vermeire et al.
LANCET (2017)
Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study
Subra Kugathasan et al.
LANCET (2017)
Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease
Nathaniel R. West et al.
NATURE MEDICINE (2017)
xCell: digitally portraying the tissue cellular heterogeneity landscape
Dvir Aran et al.
GENOME BIOLOGY (2017)
Short- and medium-term outcomes following primary ileocaecal resection for Crohn's disease in two specialist centres
A. de Buck van Overstraeten et al.
BRITISH JOURNAL OF SURGERY (2017)
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Brodalumab in Patients With Moderate-to-Severe Crohn's Disease
Stephan R. Targan et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2016)
Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease After Ileocolonic Resection
Miguel Regueiro et al.
GASTROENTEROLOGY (2016)
A Promoter Variant Within the Aryl Hydrocarbon Receptor Gene Is Associated with an Epithelial Barrier Defect in Smokers with Crohn's Disease
Matthias Prager et al.
INFLAMMATORY BOWEL DISEASES (2016)
Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study
Isabelle Cleynen et al.
LANCET (2016)
Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease
B. G. Feagan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Mercaptopurine versus placebo to prevent recurrence of Crohn's disease after surgical resection (TOPPIC): a multicentre, double-blind, randomised controlled trial
Craig Mowat et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2016)
Efficacy of thiopurines and adalimumab in preventing Crohn's disease recurrence in high-risk patients - a POCER study analysis
P. De Cruz et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Crohn's disease management after intestinal resection: a randomised trial
Peter De Cruz et al.
LANCET (2015)
Identification of inflammatory mediators in patients with Crohn's disease unresponsive to anti-TNFα therapy
Raquel Franco Leal et al.
GUT (2015)
Disease Course and Surgery Rates in Inflammatory Bowel Disease: A Population-Based, 7-Year Follow-Up Study in the Era of Immunomodulating Therapy
Marianne K. Vester-Andersen et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2014)
A Phase 2 Study of Tofacitinib, an Oral Janus Kinase Inhibitor, in Patients With Crohn's Disease
William J. Sandborn et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)
Tailored treatment according to early post-surgery colonoscopy reduces clinical recurrence in Crohn's disease: A retrospective study
Clotilde Baudry et al.
DIGESTIVE AND LIVER DISEASE (2014)
Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature
Yael Haberman et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Cytokines in inflammatory bowel disease
Markus F. Neurath
NATURE REVIEWS IMMUNOLOGY (2014)
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
William J. Sandborn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Review article: the natural history of postoperative Crohn's disease recurrence
A. Buisson et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Surgery in a Population-Based Cohort of Crohn's Disease From Olmsted County, Minnesota (1970-2004)
Laurent Peyrin-Biroulet et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial
Wolfgang Hueber et al.
GUT (2012)
Aryl Hydrocarbon Receptor-Induced Signals Up-regulate IL-22 Production and Inhibit Inflammation in the Gastrointestinal Tract
Ivan Monteleone et al.
GASTROENTEROLOGY (2011)
Development of the Crohn's Disease Digestive Damage Score, the Lemann Score
Benjamin Pariente et al.
INFLAMMATORY BOWEL DISEASES (2011)
Characterization of Intestinal Gene Expression Profiles in Crohn's Disease by Genome-wide Microarray Analysis
Colin L. Noble et al.
INFLAMMATORY BOWEL DISEASES (2010)
Azathioprine and 6-Mercaptopurine for the Prevention of Postoperative Recurrence in Crohn's Disease: A Meta-Analysis
Laurent Peyrin-Biroulet et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Infliximab Prevents Crohn's Disease Recurrence After Ileal Resection
Miguel Regueiro et al.
GASTROENTEROLOGY (2009)
Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery
J Cosnes et al.
GUT (2005)
Activation pattern of signal transducers and activators of transcription (STAT) factors in inflammatory bowel diseases
J Mudter et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation:: Evidence in Crohn disease and experimental colitis in vivo
R Atreya et al.
NATURE MEDICINE (2000)
Share Paper
